|
ZNF121 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.187500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.011600E-01 |
| Normal-vs-Stage2 |
2.489000E-01 |
| Normal-vs-Stage3 |
6.387000E-01 |
| Normal-vs-Stage4 |
4.689800E-01 |
| Stage1-vs-Stage2 |
3.120000E-01 |
| Stage1-vs-Stage3 |
1.959030E-01 |
| Stage1-vs-Stage4 |
5.588800E-01 |
| Stage2-vs-Stage3 |
2.216800E-01 |
| Stage2-vs-Stage4 |
7.874400E-01 |
| Stage3-vs-Stage4 |
4.271200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.718200E-02 |
| Normal-vs-AfricanAmerican |
1.481830E-01 |
| Normal-vs-Asian |
8.295200E-03 |
| Caucasian-vs-AfricanAmerican |
4.395800E-01 |
| Caucasian-vs-Asian |
3.510600000034E-06 |
| AfricanAmerican-vs-Asian |
2.163400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.767200E-01 |
| Normal-vs-Female |
3.695900E-02 |
| Male-vs-Female |
1.349780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.736400E-01 |
| Normal-vs-Extreme_Weight |
9.968400E-01 |
| Normal-vs-Obese |
9.335800E-02 |
| Normal-vs-Extreme_Obese |
3.642400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.991600E-01 |
| Normal_Weight-vs-Obese |
3.543000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.265200E-01 |
| Extreme_Weight-vs-Obese |
1.052410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.317000E-01 |
| Obese-vs-Extreme_Obese |
7.162600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.005640E-01 |
| Normal-vs-Age(41-60Yrs) |
1.029720E-02 |
| Normal-vs-Age(61-80Yrs) |
3.454400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.771600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.446400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.060000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.554500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.780600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.247800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.253430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.351600E-02 |
| Normal-VS-Type2 PRCC |
6.010200E-01 |
| Normal-VS-KIRP CIMP |
8.271500E-02 |
| Normal-VS-Unclassified PRCC |
1.372380E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.818300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.832200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.677600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.628400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.037810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.203600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.232600E-01 |
| Normal-vs-N1 |
1.696430E-01 |
| Normal-vs-N2 |
9.766600E-01 |
| N0-vs-N1 |
1.217050E-01 |
| N0-vs-N2 |
8.046000E-01 |
| N1-vs-N2 |
5.810200E-01 |
|
|
